A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.

NCT00269971 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Anemia
Blood Transfusion
Orthopedic Surgery

Interventions

DRUG: epoetin alfa

Sponsor

Janssen-Ortho Inc., Canada